Nanosonics Announces trophon®2 Giveback Giveaway in Support of International Infection Prevention Week

Nanosonics Announces trophon ® 2 Giveback Giveaway in Support of International Infection Prevention Week Infection Prevention Solutions Company Joins APIC to Celebrate Healthcare Heroes

Oct. 19, 2020 13:00 UTC

Nanosonics Announces trophon®2 Giveback Giveaway in Support of International Infection Prevention Week

Infection Prevention Solutions Company Joins APIC to Celebrate Healthcare Heroes

INDIANAPOLIS--(BUSINESS WIRE)-- Nanosonics (ASX: NAN), a leader in infection prevention solutions, today announced the launch of the trophon®2 Giveback Giveaway in honor of International Infection Prevention Week. With almost $300,000 in prizes, healthcare facilities can enter for a chance to win one of 14 prize packages, each worth nearly $20,000. The company is joining together with the Association for Professionals in Infection Control and Epidemiology (APIC) as a corporate champion for International Infection Prevention Week (IIPW), October 18-24.

“This year, in particular, has put infection prevention on the global stage and a spotlight on protecting public health,” said Ken Shaw, Regional president for the United States, Canada and Latin America for Nanosonics. “We want to honor those on the front lines of infection control. We recognize the fundamental role infection preventionists and health care providers play in our public health, and we value their diligent efforts to keep patients and medical staff safe, which is why we want to further support their hard work in bringing the highest standards of care to their facilities.”

In recognition of International Infection Prevention Week, Nanosonics is giving back. From October 18 -31, 2020, healthcare facilities can enter to win a trophon2 prize package, which includes a trophon2 with a one-year standard warranty, accessories and consumables, in-person service and training, and a clinical site assessment. A total of 14 winners will be selected in November 2020.

Proper ultrasound probe reprocessing can help diminish the risk of probe cross-contamination. According to an alert from The Joint Commission, 74% of all “immediate threats to life” were from improperly sterilized or high level disinfected equipment.1 Nanosonics’ trophon2 can help reduce the risk of ultrasound probe related cross infection, offering effective bactericidal, fungicidal, virucidal and mycobactericidal protection# while ensuring that high level disinfection (HLD) is performed accurately and consistently. trophon is the first HLD system in the world proven to kill native, infectious, high-risk HPV.2 The device supports compliance with the latest guidelines and minimizes staff exposure to hazardous chemicals, fumes and spills.

“We are happy to have the support of Nanosonics for IIPW,” said APIC President Connie Steed, MSN, RN, CIC, FAPIC. “APIC welcomes the healthcare companies who have joined International Infection Prevention Week as Corporate Champions. Through IIPW, we reach healthcare professionals and patients with lifesaving information about infection prevention and the importance of infection preventionists.”

IIPW is an annual awareness campaign to stimulate interest in and highlight the importance of infection prevention. As countries continue to fight against a global pandemic, COVID-19 has shown the world how crucial infection prevention and IPs truly are in keeping our communities safe. In recognition of the infection prevention and control community, the 2020 IIPW theme is “We Love IPs.”

The trophon* franchise is fast becoming the global standard of care in providing failsafe ultrasound probe reprocessing to protect patients from the risk of cross contamination. With almost 24,000 trophon systems installed worldwide, protecting approximately 20 million patients from the risk of ultrasound probe cross-contamination annually, trophon is transforming high-level disinfection.

About Nanosonics

Nanosonics (ASX:NAN) is a leading medical technology company headquartered in Sydney, Australia, with its North American operations based in Indianapolis. Founded in 2001, the company is one of Australia’s largest medical technology companies and a recognized leader in its sector of the global infection control market. More information may be found at www.nanosonics.us.

  1. The Joint Commission (TJC). Improperly sterilized or HLD equipment – a growing problem. May 2017. Available at: https://www.jointcommission.org/assets/1/23/qs_33a_2017.pdf
  2. Ryndock E, Robison R, Meyers C. Susceptibility of HPV16 and 18 to high-level disinfectants indicated for semi-critical ultrasound probes. J Med Virol. 2016;88(6):1076-80.

# Nanosonics internal test data

*trophon [trophon EPR & trophon2]

Contacts

Media Contact:
Amy Cook
amy@amcpublicrelations.net

Source: Nanosonics

MORE ON THIS TOPIC